Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Haematology International Journal Research Article 27 min read

Immunomodulatory Effects of Blood Transfusion in HIV-Positive Pediatric Severe Malaria Patients: A Review

Emmanuel Ifeanyi Obeagu* and Getrude Uzoma Obeagu*
* Corresponding author
ISSN: 2578-501X  10.23880/hij-16000245  Received: March 14, 2024  Published: April 01, 2024
 — views
 113 references
PDF
Keywords
Immunomodulatory Effects Blood Transfusion HIV Pediatrics Malaria Plasmodium Falciparum
Abstract

This paper explores the intricate interplay between HIV infection, severe malaria, and blood transfusion in pediatric patients. With a focus on the immunomodulatory effects of blood transfusion, we delve into the complex dynamics that govern these overlapping health challenges. This review aims to contribute to a nuanced approach to care, fostering improved outcomes and better-informed healthcare decisions for HIV-positive pediatric severe malaria patients requiring blood transfusion. The immunopathogenesis of HIV and severe malaria sets the stage for understanding the unique vulnerabilities of coinfected children. Blood transfusion, a critical intervention for severe anemia, is examined in the context of its impact on immune responses in HIV-positive pediatric severe malaria patients. The paper synthesizes existing knowledge on transfusion-related immune modulation (TRIM) and navigates through challenges and controversies surrounding this therapeutic strategy. Future perspectives and recommendations underscore the need for further research to enhance our understanding and guide clinical practice in managing this complex patient population.

Emmanuel Ifeanyi Obeagu1 and Getrude Uzoma Obeagu2

practice in managing this complex patient population.

Introduction

The coexistence of HIV infection and severe malaria in pediatric patients presents a formidable challenge in the realm of global health. Both diseases independently contribute significantly to childhood morbidity and mortality, particularly in regions where they are endemic. When these two health burdens overlap, the complexity of clinical management increases, necessitating a comprehensive understanding of the immunomodulatory effects of therapeutic interventions, such as blood transfusion. HIV, a retrovirus that primarily targets the immune system’s CD4+ T cells, compromises the body’s ability to mount an effective defense against various pathogens. The resulting immunodeficiency renders individuals susceptible to opportunistic infections and increases the severity of other coexisting diseases. In parallel, severe malaria, caused predominantly by Plasmodium falciparum, exerts its pathogenic effects by invading and replicating within red blood cells, leading to anemia, organ dysfunction, and potentially fatal complications. Understanding the individual immunopathogenesis of these diseases is crucial to comprehend the challenges faced by HIV-positive pediatric patients with severe malaria [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16].

Blood transfusion emerges as a critical therapeutic intervention in the management of severe malaria, particularly when life-threatening anemia ensues. However, the immunomodulatory effects of blood transfusion in the context of HIV infection remain insufficiently elucidated. This review aims to bridge this knowledge gap by examining existing literature and synthesizing evidence on how blood transfusion influences the immune responses in pediatric severe malaria patients with coexisting HIV infection. By doing so, we strive to provide insights that can inform clinical decision-making and optimize the care of this vulnerable patient population. The immunomodulatory landscape becomes even more complex when considering the phenomenon of Transfusion-Related Immune Modulation (TRIM). While blood transfusion aims to alleviate severe anemia, it may inadvertently modulate the recipient’s immune system, potentially impacting the progression of HIV infection and the severity of malaria symptoms. This review seeks to unravel the intricacies of TRIM in HIV- positive pediatric severe malaria patients, shedding light on the underlying mechanisms that govern the immune response post-transfusion [17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33].

This review aims to contribute to a nuanced approach to care, fostering improved outcomes and better-informed healthcare decisions for HIV-positive pediatric severe malaria patients requiring blood transfusion.

The Immunopathogenesis of HIV and Severe Malaria

The immunopathogenesis of HIV and severe malaria involves complex interactions between the pathogens and the host immune system, resulting in distinct immunological profiles that contribute to the severity of each disease. Understanding these processes is crucial for developing effective therapeutic strategies, especially in the context of co- infection. HIV, a lentivirus belonging to the retrovirus family, primarily targets CD4+ T cells, which play a central role in orchestrating immune responses. The virus enters these cells, integrates its genetic material into the host genome, and subsequently hijacks the cellular machinery for replication. The progressive depletion of CD4+ T cells compromises the immune system’s ability to mount an effective response against opportunistic infections and malignancies. Additionally, HIV induces chronic immune activation and inflammation, contributing to the pathogenesis of AIDS. The immunodeficiency caused by HIV creates a vulnerable state, making individuals more susceptible to various infections and complicating the clinical course of coexisting diseases [34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53].

Severe malaria, caused predominantly by Plasmodium falciparum, unfolds through a series of intricate interactions between the parasite and the host’s immune system. The parasite’s life cycle involves stages within both the human host and the Anopheles mosquito vector. During blood-stage infection, the malaria parasite invades red blood cells, leading to cycles of replication and release of merozoites, resulting in anemia and organ dysfunction. The host’s immune response is characterized by the activation of innate immune cells, such as macrophages and dendritic cells, as well as the induction of adaptive immune responses mediated by T cells and antibodies. However, the parasite has evolved various immune evasion mechanisms, such as antigenic variation and sequestration in deep tissues, complicating the host’s ability to eliminate the infection efficiently. When HIV and severe malaria coexist, the immunopathogenesis becomes even more intricate. The immunosuppressive effects of HIV exacerbate the vulnerability to severe malaria, leading to increased parasite burdens and more severe clinical manifestations. Additionally, the chronic immune activation induced by HIV may further heighten the inflammatory responses associated with severe malaria, contributing to exaggerated cytokine cascade and organ damage. The reciprocal influence of these two infections creates a synergistic effect, necessitating a careful examination of the immunomodulatory effects of therapeutic interventions, such as blood transfusion, in this specific patient population [54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76].

Blood Transfusion in Pediatric Severe Malaria

The management of pediatric severe malaria often involves blood transfusion as a critical intervention, particularly when severe anemia poses a life-threatening risk to the young patients. Severe anemia is a common complication of malaria, primarily caused by the destruction of red blood cells as the malaria parasite progresses through its life cycle. In pediatric cases, where the consequences of anemia can be swift and severe, blood transfusion becomes a life-saving measure. The primary indication for blood transfusion in pediatric severe malaria is the development of severe anemia, a condition that significantly contributes to the morbidity and mortality associated with the disease. Malaria- induced hemolysis, coupled with the parasitic invasion of red blood cells, leads to a rapid decline in hemoglobin levels. Blood transfusion serves to replenish red blood cells, restore oxygen-carrying capacity, and prevent cardiovascular collapse. This intervention is particularly crucial in resource- limited settings where access to alternative therapies may be constrained. The immediate and tangible benefit of blood transfusion in pediatric severe malaria lies in its ability to reverse the life-threatening consequences of severe anemia.

By increasing the hemoglobin levels, transfusion restores oxygen delivery to vital organs, alleviates symptoms such as fatigue and lethargy, and improves overall clinical outcomes. Timely and appropriately administered transfusions can be instrumental in preventing complications such as organ failure and cerebral malaria, which are associated with high mortality rates in severe cases [78, 79, 80, 81, 82, 83, 84, 85].

Despite its life-saving potential, blood transfusion is not without risks, especially in resource-limited settings where screening for infectious diseases and blood typing may be limited. Transfusion-related infections, such as malaria and HIV, can inadvertently be transmitted, underscoring the importance of rigorous screening protocols. Additionally, transfusion reactions, including hemolytic reactions or immunomodulatory effects, pose challenges that need to be carefully considered. Balancing the benefits and risks of blood transfusion in the context of pediatric severe malaria requires a nuanced approach and close monitoring of patients. To enhance the effectiveness and safety of blood transfusion in pediatric severe malaria, ongoing research focuses on optimizing transfusion strategies. This includes determining the appropriate threshold for transfusion initiation, exploring alternative therapies, and refining screening protocols to minimize the risk of transfusion- related infections. By addressing these challenges, healthcare providers can tailor transfusion strategies to the unique needs of pediatric severe malaria patients, ensuring maximal benefit while minimizing potential risks [86, 87, 88, 89, 90, 91, 92, 93, 94, 95].

Impact of Blood Transfusion on Immune Responses

Understanding the impact of blood transfusion on immune responses is crucial, especially in the context of pediatric severe malaria patients coinfected with HIV. The immune system plays a pivotal role in both the clearance of the malaria parasite and the progression of HIV infection, making it essential to examine how transfusion influences immune dynamics in this complex scenario. Blood transfusion has the potential to modulate various components of the immune system, affecting both innate and adaptive immunity. Immunomodulation can occur through the introduction of donor immune cells, bioactive molecules, or alterations in the recipient’s cytokine milieu. In the case of pediatric severe malaria patients with HIV coinfection, understanding how transfusion influences immune cell function, including T cells, B cells, and phagocytes, is crucial for assessing its impact on the overall immune response to both pathogens. Transfusion- induced changes in cytokine profiles and inflammatory responses can significantly impact the course of both HIV and severe malaria. The release of cytokines during transfusion may influence the balance between pro-inflammatory and anti-inflammatory signals, potentially exacerbating or ameliorating ongoing immune responses. In the context of pediatric patients coinfected with HIV and severe malaria, determining how transfusion alters cytokine dynamics is essential for predicting the potential immunomodulatory effects on disease progression and severity.

Maintaining immune homeostasis is crucial for effective responses to both HIV and severe malaria. Blood transfusion, while addressing immediate concerns such as anemia, may perturb the delicate balance of immune regulatory mechanisms. Moreover, in the context of HIV, transfusion- related immunosenescence - the premature aging of the immune system—may have implications for the long-term control of the virus and the susceptibility to opportunistic infections. Exploring the impact of transfusion on immune homeostasis and potential immunosenescence is essential for comprehensively understanding the consequences of this therapeutic intervention. Blood transfusion may influence the pathogen-specific immune responses crucial for controlling both HIV and malaria. Understanding how transfusion affects the development of adaptive immunity, including the generation of specific antibodies and memory T cells, is critical. In the context of pediatric severe malaria patients with HIV, determining whether transfusion enhances or hinders the development of protective immunity is essential for optimizing patient outcomes. The long-term immunological consequences of blood transfusion in pediatric severe malaria patients with HIV remain an area of active investigation. Assessing the persistence of immunomodulatory effects, potential alterations in immune memory, and the impact on the natural history of both infections is essential for guiding clinical decisions and developing strategies to mitigate adverse outcomes [96, 97, 98, 99, 100, 101, 102, 103, 104].

Conclusion

The intricate interplay between HIV infection, severe malaria, and blood transfusion in pediatric patients poses a complex challenge that demands a nuanced understanding of the immunomodulatory effects at play. Blood transfusion, a critical intervention in the management of severe malaria- induced anemia, adds an additional layer of complexity with its potential impact on immune responses. The immunomodulatory effects of blood transfusion, particularly in the context of Transfusion-Related Immune Modulation (TRIM), were dissected to uncover the intricate dynamics that influence immune cell function, cytokine profiles, and overall immune homeostasis. Understanding the immediate and long-term consequences of blood transfusion in pediatric severe malaria patients with HIV coinfection is paramount for optimizing clinical decision-making and improving patient outcomes.

References

  1. Benatar S, Brock G (2011) Global Health and Global Health Ethics. 1st (Edn.), Cambridge University Press, pp: 352.
  2. Benatar S, Brock G (2021), Global Health Ethical Challenges. 2nd (Edn.), Cambridge University Press, pp: 510.
  3. Obeagu EI, Okwuanaso CB, Edoho SH, Obeagu GU (2022) Under-Nutrition among HIV-Exposed Uninfected Children a Review of African Perspective. Madonna University Journal of Medicine and Health Sciences 2(3): 120-127.
  4. Obeagu EI, Alum EU, Obeagu GU (2023) Factors Associated With Prevalence of HIV among Youths a Review of Africa Perspective. Madonna University Journal of Medicine and Health Sciences 3(1): 13-18.
  5. Obeagu EI (2023) A Review of Challenges and Coping Strategies Faced by HIV/AIDS Discordant Couples. Madonna University journal of Medicine and Health Sciences 3(1): 7-12.
  6. Obeagu EI, Obeagu GU (2023) An Update on Premalignant Cervical Lesions and Cervical Cancer Screening Services among HIV Positive Women. J Pub Health Nutri 6(2): 141.
  7. Ezeoru VC, Enweani IB, Ochiabuto O, Nwachukwu AC, Ogbonna US, et al. (2021) Prevalence of Malaria with Anaemia and HIV Status in Women of Reproductive Age in Onitsha Nigeria. Journal of Pharmaceutical Research International 33(4): 10-19.
  8. Emmanuel OUK, Chinedum OK, Obeagu EI (2017) Evaluation of Laboratory Logistics Management Information System in HIV/AIDS Comprehensive Health Facilities in Bayelsa State Nigeria. Int J Curr Res Med Sci 3(1): 21-38.
  9. Obeagu EI, Obeagu GU, Musiimenta E, Bot YS, Hassan AO (2023) Factors Contributing to Low Utilization of HIV Counseling and Testing Services. Int J Curr Res Med Sci 9(2): 1-5.
  10. Obeagu EI, Obeagu GU (2022) An Update on Survival of People Living with HIV in Nigeria. J Pub Health Nutri 5(6): 129.
  11. Offie DC, Obeagu EI, Akueshi C, Njab JE, Ekanem EE, et al. (2021) Facilitators and Barriers to Retention in HIV Care among HIV Infected MSM Attending Community Health Center Yaba Lagos Nigeria. Journal of Pharmaceutical Research International 33(52B): 10-19.
  12. Obeagu EI, Obeagu GU, Obiezu J, Ezeonwumelu C, Ogunnaya FU, et al. (2023) Hematologic Support in HIV Patients Blood Transfusion Strategies and Immunological Considerations. Newport International Journal of Biological and Applied Sciences (NIJBAS) 3(3).
  13. Obeagu EI, Obeagu GU (2024) Hematological Changes Following Blood Transfusion in Young Children with Severe Malaria and HIV a Critical Review. Elite Journal of Laboratory Medicine 2(1): 33-45.
  14. Obeagu EI, Obeagu GU (2024) The Role of Blood Transfusion Strategies in HIV Management Current Insights and Future Directions. Elite Journal of Medicine 2(1): 10-22.
  15. Obeagu EI, Obeagu GU (2024) Advances in Understanding the Impact of Blood Transfusion on Anemia Resolution in HIV Positive Children with Severe Malaria a Comprehensive Review. Elite Journal of Haematology 2(1): 26-41.
  16. Obeagu EI, Babar Q, Obeagu GU (2021) Allergic blood Transfusion reaction a Review. Int J Curr Res Med Sci 7(5): 25-33.
  17. Obeagu EI, Ubosi NI, Uzoma G (2023) Maternal Hemorrhage and Blood Transfusions Safeguarding Pregnancy Health. Int J Curr Res Chem Pharm Sci 10(11): 26-35.
  18. Obeagu EI, Obeagu GU (2024) Transfusion Related Complications in Children Under 5 with Coexisting HIV and Severe Malaria a Review. Int J Curr Res Chem Pharm Sci 11(2): 9-19.
  19. ObeaguEI AA, Obeagu GU (2024) Synergistic Effects of Blood Transfusion and HIV in Children Under 5 Years with Severe Malaria a Review. Elite Journal of HIV 2(1): 31-50.
  20. Obeagu EI, Anyiam AF, Obeagu GU (2024) Managing Anemia in HIV through Blood Transfusions: Clinical Considerations and Innovations. Elite Journal of HIV 2(1): 16-30.
  21. Obeagu EI, Obeagu GU (2024) Transfusion Therapy in HIV: Risk Mitigation and Benefits for Improved Patient Outcomes. Asian Journal of Dental and Health Sciences 4(1): 32-37.
  22. Obeagu EI, Obeagu GU, Obiezu J, Ezeonwumelu C, Ogunnaya FU, et al. (2023) Immunomodulatory Effects of Transfusions on Maternal Immunity in Pregnancy. Newport International Journal of Biological and Applied Sciences (NIJBAS) 3(3).
  23. Odo M, Ochei KC, Obeagu EI, Barinaadaa A, Eteng UE, et al. (2020) TB Infection Control in TB/HIV Settings in Cross River State Nigeria Policy Vs Practice. Journal of Pharmaceutical Research International 32(22): 101- 109.
  24. Obeagu EI, Eze VU, Alaeboh EA, Ochei KC (2016) Determination of Haematocrit Level and Iron Profile Study among Persons Living with HIV in Umuahia, Abia State Nigeria. J Bio Innovation 5(4): 464-471.
  25. Ifeanyi OE, Obeagu GU (2015) The Values of Prothrombin Time among HIV Positive Patients in FMC Owerri. International Journal of Current Microbiology and Applied Sciences 4(4): 911-916.
  26. Izuchukwu IF, Ozims SJ, Agu GC, Obeagu EI, Onu I, et al. (2016) Knowledge of Preventive Measures and Management of HIV/AIDS Victims among Parents in Umuna Orlu Community of Imo State Nigeria. Int J Adv Res Biol Sci 3(10): 55-65.
  27. Chinedu K, Takim AE, Obeagu EI, Chinazor UD, Eloghosa O, et al. (2017) HIV and TB Co-Infection among Patients Who used Directly Observed Treatment Short Course Centres in Yenagoa, Nigeria. IOSR J Pharm Biol Sci 12(4): 70-75.
  28. Oloro OH, Oke TO, Obeagu EI (2022) Evaluation of Coagulation Profile Patients with Pulmonary Tuberculosis and Human Immunodeficiency Virus in Owo Ondo State Nigeria. Madonna University journal of Medicine and Health Sciences 2(3): 110-119.
  29. Nwosu DC, Obeagu EI, Nkwocha BC, Nwanna CA, Nwanjo HU, et al. (2016) Change in Lipid Peroxidation Marker (MDA) and Non enzymatic Antioxidants (VIT C & E) in HIV Seropositive Children in an Urban Community of Abia State. Nigeria J Bio Innov 5(1): 24-30.
  30. Igwe CM, Obeagu IE, Ogbuabor OA (2022) Clinical Characteristics of People Living With HIV/AIDS on ART in 2014 at Tertiary Health Institutions in Enugu Nigeria. J Pub Health Nutri 5(6): 130.
  31. Ifeanyi OE, Obeagu GU, Ijeoma FO, Chioma UI (2015) The Values of Activated Partial Thromboplastin Time (APTT) among HIV Positive Patients in FMC Owerri. Int J Curr Res Aca Rev 3(4): 139-144.
  32. Obiomah CF, Obeagu EI, Ochei KC, Swem CA, Amachukwu BO (2018) Hematological Indices of HIV Seropositive Subjects in Nnamdi Azikiwe University Teaching Hospital (NAUTH) Nnewi. Ann Clin Lab Res 6(1):1-4.
  33. Emmanuel OUK, Ochei KC, Osuala EO, Obeagu EI, Onwuasoanya UF (2017) Impact of Prevention of Mother to Child Transmission (PMTCT) of HIV on Positivity Rate in Kafanchan Nigeria. Int J Curr Res Med Sci 3(2): 28-34.
  34. Aizaz M, Abbas FA, Abbas A, Tabassum S, Obeagu EI (2023) Alarming Rise in HIV Cases in Pakistan Challenges and Future Recommendations at Hand. Health Science Reports 6(8): e1450.
  35. Obeagu EI, Amekpor F, Scott GY (2023) An Update of Human Immunodeficiency Virus Infection Bleeding Disorders. J Pub Health Nutri 6 (1): 139.
  36. Obeagu EI, Scott GY, Amekpor F, Ofodile AC, Edoho SH, et al. (2022) Prevention of New Cases of Human Immunodeficiency Virus Pragmatic Approaches of Saving Life in Developing Countries. Madonna University journal of Medicine and Health Sciences 2(3): 128-134.
  37. Walter O, Anaebo QB, Obeagu EI, Okoroiwu IL (2022) Evaluation of Activated Partial Thromboplastin Time and Prothrombin Time in HIV and TB Patients in Owerri Metropolis. Journal of Pharmaceutical Research International 34(3A): 29-34.
  38. Odo M, Ochei KC, Obeagu EI, Barinaadaa A, Eteng EU, et al. (2020) Cascade Variabilities in TB Case Finding among People Living with HIV and the use of IPT: Assessment in Three Levels of Care in Cross River State Nigeria. Journal of Pharmaceutical Research International 32(24): 9-18.
  39. Jakheng SP, Obeagu EI (2022) Seroprevalence of Human Immunodeficiency Virus Based on Demographic and Risk Factors among Pregnant Women Attending Clinics in Zaria Metropolis Nigeria. J Pub Health Nutri 5(8): 137.
  40. Obeagu EI, Obeagu GU (2023) A Review of Knowledge Attitudes and Socio Demographic Factors Associated with Non Adherence to Antiretroviral Therapy among People Living with HIV/AIDS. Int J Adv Res Biol Sci 10(9): 135-142.
  41. Obeagu EI, Onuoha EC (2023) Tuberculosis among HIV Patients a review of Prevalence and Associated Factors. Int J Adv Res Biol Sci 10(9): 128-134.
  42. Obeagu EI, Ibeh NC, Nwobodo HA, Ochei KC, Iwegbulam CP (2017) Haematological Indices of Malaria Patients Coinfected with HIV in Umuahia. Int J Curr Res Med Sci 3(5): 100-104.
  43. Jakheng SP, Obeagu EI, Abdullahi IO, Jakheng EW, Chukwueze CM, et al. (2022) Distribution Rate of Chlamydial Infection According to Demographic Factors among Pregnant Women Attending Clinics in Zaria Metropolis Kaduna State Nigeria. South Asian Journal of Research in Microbiology 13(2): 26-31.
  44. Obeagu EI, Babar Q, Uduchi IO, Ibekwe AM, Chijioke UO, et al. (2021) An Update on Transfusion Related Immunomodulation (TRIM) in a Time of COVID-19 Pandemic. Journal of Pharmaceutical Research International 33(42A): 135-146.
  45. Okoroiwu IL, Obeagu EI, Elemchukwu Q, Ochei KC, Christian GS (2015) Frequency of Transfusion Reactions Following Compatible Cross Matching of Blood a Study in Owerri Metropolis. International Journal of Current Research and Academic Review 3(1): 155-160.
  46. Obeagu EI, Oshim IO, Ochei KC, Obeagu GU (2016) Iron and Blood Donation a Review. Int J Curr Res Med Sci 2(10): 16-48.
  47. Ogar CO, Okoroiwu HU, Obeagu EI, Etura JE, Abunimye DA (2021) Assessment of Blood Supply and Usage Pre and during COVID-19 Pandemic a Lesson from Non Voluntary Donation. Transfusion Clinique Biologique 28(1): 68-72.
  48. Anyiam AF, Arinze-Anyiam OC, Irondi EA, Obeagu EI (2023) Distribution of ABO and Rhesus Blood Grouping with HIV Infection among Blood Donors in Ekiti State Nigeria. Medicine 102(47): e36342.
  49. Obeagu EI, Obeagu GU, Chukwueze CM, Ikpenwa JN, Ramos GF (2022) Evaluation of Protein C, Protein S And Fibrinogen of Pregnant Women with Malaria in Owerri Metropolis. Madonna University journal of Medicine and Health Sciences 2(2): 1-9.
  50. Opeyemi AA, Obeagu EI (2023) Regulations of Malaria in Children with Human Immunodeficiency Virus Infection a Review. Medicine 102(46): e36166.
  51. Obeagu EI, Chijioke UO, Ekelozie IS (2018) Malaria rapid diagnostic test (RDTs). Ann Clin Lab Res 6(4):275.
  52. Obeagu EI, Alum EU, Ugwu OPC (2023) Hepcidin: The Gatekeeper of Iron in Malaria Resistance.
  53. Ogomaka IA, Obeagu EI (2019) Methods of Breast Feeding as Determinants of Malaria Infections among Babies in IMO State Nigeria. International Journal of Medical Science and Dental Research 2(1): 17-24.
  54. Obeagu EI, Obeagu GU, Egba SI, Emeka-Obi OR (2023) Combatting Anemia in Pediatric Malaria Effective Management Strategies. Int J Curr Res Med Sci 9(11): 1-7.
  55. Hassan AO, Oso OV, Obeagu EI, Adeyemo AT (2022) Malaria Vaccine Prospects and Challenges. Madonna University Journal of Medicine and Health Sciences 2(2): 22-40.
  56. Obeagu EI, Busari AI, Uduchi IO, Ogomaka IA, Ibekwe AM, et al. (2021) Age Related Haematological Variations in Patients with Asymptomatic Malaria in Akure Ondo State Nigeria. Journal of Pharmaceutical Research International 33(42B): 218-224.
  57. Ogomaka IA, Obeagu EI (2021) Malaria in Pregnancy Amidst Possession of Insecticide Treated Bed Nets (ITNs) in Orlu LGA of Imo State Nigeria. Journal of Pharmaceutical Research International 33(41B): 380- 386.
  58. Obeagu EI (2020) Blood Transfusion A Powerful Process of Saving Anaemic Patients. EC Emergency Medicine and Critical Care 4(7): 33-40.
  59. Obeagu EI, Buhari HA (2023) Implications of Blood Transfusion in Renal Disease Patients. Int J Curr Res Chem Pharm Sci 10(10): 45-49.
  60. Anyiam AF, Arinze-Anyiam OC, Omosigho PO, Ibrahim M, Irondi EA, et al. (2022) Blood Group, Genotype, Malaria, Blood Pressure and Blood Glucose Screening Among Selected Adults of a Community in Kwara State Implications to Public Health. Asian Hematology Research Journal 6(3):9-17.
  61. Obeagu EI, Obeagu GU, Ukibe NR, Oyebadejo SA (2024) Anemia, Iron, and HIV Decoding the Interconnected Pathways a Review. Medicine 103(2): e36937.
  62. Obeagu EI (2019) An Update on Susceptibility of Individuals to Diseases Based on ABO Blood Groups. Int J Curr Res Med Sci 5(3): 1-8.
  63. Viola N, Kimono E, Nuruh N, Obeagu EI (2023) Factors Hindering Elimination of Mother to Child Transmission of HIV Service Uptake among HIV Positive Women at Comboni Hospital Kyamuhunga Bushenyi District. Asian Journal of Dental and Health Sciences 3(2): 7-14.
  64. Okorie HM, Obeagu Emmanuel I, Okpoli Henry CH, Chukwu Stella N (2020) Comparative Study of Enzyme Linked Immunosorbent Assay (Elisa) and Rapid Test Screening Methods on HIV, HBsAg, HCV and Syphilis among Voluntary Donors in Owerri Nigeria. J Clin Commun Med 2(3): 180-183.
  65. Ezugwu UM, Onyenekwe CC, Ukibe NR, Ahaneku JE, Onah CE, et al. (2021) Use of ATP, GTP, ADP and AMP as an Index of Energy Utilization and Storage in HIV Infected Individuals at NAUTH, Nigeria a Longitudinal, Prospective, Case-Controlled Study. Journal of Pharmaceutical Research International 33(47A): 78-84.
  66. Emannuel G, Martin O, Peter OS, Obeagu EI, Daniel K (2023) Factors Influencing Early Neonatal Adverse Outcomes among Women with HIV with Post Dated Pregnancies Delivering at Kampala International University Teaching Hospital, Uganda. Asian Journal of Pregnancy and Childbirth 6(1): 203-211.
  67. Igwe MC, Obeagu EI, Ogbuabor AO, Eze GC, Ikpenwa JN, et al. (2022) Socio-Demographic Variables of People Living with HIV/AIDS Initiated on ART in 2014 at Tertiary Health Institution in Enugu State. Asian Journal of Research in Infectious Diseases 10(4): 1-7.
  68. Vincent CC, Obeagu EI, Agu IS, Ukeagu NC, Onyekachi- Chigbu AC (2021) Adherence to Antiretroviral Therapy among HIV/AIDS in Federal Medical Centre Owerri. Journal of Pharmaceutical Research International 33(57A): 360-368.
  69. Igwe MC, Obeagu EI, Ogbuabor AO (2022) Analysis of the Factors and Predictors of Adherence to Healthcare of People Living with HIV/AIDS in Tertiary Health Institutions in Enugu State. Madonna University journal of Medicine and Health Sciences 2(3): 42-57.
  70. Madekwe CC, Madekwe CC, Obeagu EI (2022) Inequality of Monitoring in Human Immunodeficiency Virus Tuberculosis and Malaria a Review. Madonna University journal of Medicine and Health Sciences 2(3): 6-15.
  71. Echendu GE, Vincent CC, Ibebuike J, Asodike M, Naze N, et al. (2023) Weights of Infants Born to HIV Infected Mothers a Prospective Cohort Study in Federal Medical Centre Owerri Imo State. European Journal of Pharmaceutical and Medical Research 10(8): 564-568.
  72. Nwosu DC, Nwanjo HU, Okolie NJ, Ikeh K, Ajero CM, et al. (2015) Biochemical Alterations in Adult HIV Patients on Antiretrqviral Therapy. World Journal of Pharmacy and Pharmaceutical Sciences 4(3): 153-160.
  73. Ogbonna CO, Obeagu EI, Ufelle SA, Ogbonna LN (2021) Evaluation of Haematological Alterations in Children Infected by Plasmodium Falciparum Species in Enugu, Enugu State, Nigeria. Journal of Pharmaceutical Research International 33(1): 38-45.
  74. Okorie HM, Obeagu EI, Obarezi HC, Anyiam AF (2019) Assessment of Some Inflammatory Cytokines in Malaria Infected Pregnant Women in Imo State Nigeria. International Journal of Medical Science and Dental Research 2(1): 25-36.
  75. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA (2018) Assessment of Some Haematological Parameters in Malaria Infected Pregnant Women in Imo State Nigeria. Int J Curr Res Biol Med 3(9): 1-4.
  76. Nwosu DC, Obeagu EI, Ezenwuba C, Agu GC, Amah H, et al. (2016) Antioxidant Status of Children with Plasmodium Falciparum Malaria in Owerri Municipal Council of Imo state. Int J Curr Res Chem Pharm Sci 3(8): 40-46.
  77. Eze R, Obeagu EI, Nwakulite A, Vincent CC, Ogbodo SO, et al. (2021) Frequency of Haemoglobin Genotype Variants, ABO and Rh ‘D’Antigen among Madonna Undergraduates of South East Origin, Nigeria. Journal of Pharmaceutical Research International 33(29B): 149-57.
  78. Okoroiwu IL, Obeagu EI, Christian SG, Elemchukwu Q, Ochei KC (2015) Determination of the Haemoglobin, Genotype and ABO Blood Group Pattern of Some Students of Imo State University, Owerri, Nigeria. International Journal of Current Research and Academic Review 3(1): 20-27.
  79. Oloro OH, Obeagu EI, Puche RO, Lawal OA (2022) Blood Products in Blood Banking Preparation and Clinical Importance. Madonna University journal of Medicine and Health Sciences 2(3): 102-109.
  80. Asemota EA, Njar VE, Aguanah IT, Obeagu EI (2023) Distribution of ABO, Rhesus Blood Group and Helicobacter Pylori Infection among Secondary School Students in Calabar South Local Government, Cross River State, Nigeria. Madonna University journal of Medicine and Health Sciences 3(1): 32-45.
  81. Obeagu EI, Katya MC (2022) A Systematic Review on Physiological Jaundice Diagnosis and Management of the Affected Neonates. Madonna University journal of Medicine and Health Sciences 2(3): 25-41.
  82. Okamgba OC, Nwosu DC, Nwobodo EI, Agu GC, Ozims SJ, et al. (2017) Iron Status of Pregnant and Post Partum Women with Malaria Parasitaemia in Aba Abia State, Nigeria. Annals of Clinical and Laboratory Research 5(4): 206.
  83. Obeagu EI, Nimo OM, Bunu UO, Ugwu OP, Alum EU (2023) Anaemia in Children Under Five Years African Perspectives. Int J Curr Res Biol Med 8(1): 1-7.
  84. Madekwe CC, Madekwe CC, Obeagu EI (2022) Inequality of Monitoring in Human Immunodeficiency Virus, Tuberculosis and Malaria a Review. Madonna University journal of Medicine and Health Sciences 2(3): 6-15.
  85. Offie DC, Ibekwe AM, Agu CC, Esimai BN, Okpala PU, et al. (2021) Fibrinogen and C Reactive Protein Significance in Children Infected by Plasmodium falciparum Species in Enugu, Enugu State, Nigeria. Journal of Pharmaceutical Research International 33(15): 1-8.
  86. Obeagu EI, Obeagu GU (2015) Effect of CD4 Counts on Coagulation Parameters among HIV Positive Patients in Federal Medical Centre, Owerri, Nigeria. Int J Curr Res Biosci Plant Biol 2(4): 45-49.
  87. Obeagu EI, Nwosu DC (2019) Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy a Review of Prevalence. Int J Curr Res Chem Pharm Sci 6(12): 45-8.
  88. Obeagu EI, Scott GY, Amekpor F, Obeagu GU (2023) Implications of CD4/CD8 Ratios in Human Immunodeficiency Virus Infections. Int J Curr Res Med Sci 9(2): 6-13.
  89. Obeagu EI, Ochei KC, Okeke EI, Anode AC (2016) Assessment of the Level of Haemoglobin and Erythropoietin in Persons Living with HIV in Umuahia. Int J Curr Res Med Sci 2(4): 29-33.
  90. Ifeanyi OE, Obeagu GU (2015) The Values of CD4 Count, among HIV Positive Patients in FMC Owerri. Int J Curr Microbiol App Sci 4(4): 906-910.
  91. Obeagu EI, Okeke EI, Andrew AC (2016) Evaluation of Haemoglobin and Iron Profile Study among Persons Living With HIV in Umuahia, Abia State, Nigeria. Int J Curr Res Biol Med 1(2): 1-5.
  92. Alum EU, Ugwu OP, Obeagu EI, Okon MB (2023) Curtailing HIV/AIDS Spread Impact of Religious Leaders. Newport International Journal of Research in Medical Sciences (NIJRMS) 3(2): 28-31.
  93. Obeagu EI, Obeagu GU, Paul-Chima UO (2023) Stigma Associated With HIV/AIDS a Review. Newport International Journal of Public Health and Pharmacy (NIJPP) 3(2): 64-67.
  94. Alum EU, Obeagu EI, Ugwu OP, Aja PM, Okon MB (2023) HIV Infection and Cardiovascular Diseases the Obnoxious Duos. Newport International Journal of Research in Medical Sciences (NIJRMS) 3(2): 95-99.
  95. Ibebuike JE, Nwokike GI, Nwosu DC, Obeagu EI (2018) A Retrospective Study on Human Immune Deficiency Virus among Pregnant Women Attending Antenatal Clinic in Imo State University Teaching Hospital. International Journal of Medical Science and Dental Research 1(2): 08- 14.
  96. Obeagu EI, Obarezi TN, Omeh YN, Okoro NK, Eze OB (2014) Assessment of Some Haematological and Biochemical Parametrs in HIV Patients Before Receiving Treatment in Aba, Abia State, Nigeria. Res J Pharma Biol Chem Sci 5(2): 825-830.
  97. Obeagu EI, Obarezi TN, Ogbuabor BN, Anaebo QB, Eze GC (2014) Pattern of Total White Blood Cell and Differential Count Values in HIV Positive Patients Receiving Treatment in Federal Teaching Hospital Abakaliki, Ebonyi State, Nigeria. International Journal of Life Science, Biotechnology and Pharama Research 3(1): 186-189.
  98. Oloro OH, Obeagu EI (2022) A Systematic Review on Some Coagulation Profile in HIV Infection. International Journal of Innovative and Applied Research 10(5): 1-11.
  99. Nwosu DC, Obeagu EI, Nkwuocha BC, Nwanna CA, Nwanjo HU, et al. (2015) Alterations in Superoxide Dismutiase, Vitamins C and E in HIV Infected Children in Umuahia, Abia State. International Journal of Advanced Research in Biological Sciences 2(11): 268-271.
  100. Obeagu EI, Malot S, Obeagu GU, Ugwu OP (2023) HIV Resistance in Patients with Sickle Cell Anaemia. Newport International Journal of Scientific and Experimental Sciences (NIJSES) 3(2): 56-59.
  101. Ifeanyi OE, Uzoma OG, Stella EI, Chinedum OK, Abum SC (2018) Vitamin D and Insulin Resistance in HIV Sero Positive Individuals in Umudike. Int J Curr Res Med Sci 4(2): 104-108.
  102. Ifeanyi OE, Leticia OI, Nwosu D, Chinedum OK (2018) A Review on Blood Borne Viral Infections Universal Precautions. Int J Adv Res Biol Sci 5(6): 60-66.
  103. Nwovu AI, Ifeanyi OE, Uzoma OG, Nwebonyi NS (2018) Occurrence of Some Blood Borne Viral Infection and Adherence to Universal Precautions among Laboratory Staff in Federal Teaching Hospital Abakaliki Ebonyi State. Arch Blood Transfus Disord 1(2).
  104. Offie DC, Obeagu EI, Akueshi C, Njab JE, Ekanem EE, et al. (2021) Facilitators and Barriers to Retention in HIV Care among HIV Infected MSM Attending Community Health Center Yaba, Lagos Nigeria. Journal of Pharmaceutical Research International 33(52B): 10-
  105. Goubran H, Sheridan D, Radosevic J, Burnouf T, Seghatchian J (2017) Transfusion Related Immunomodulation and Cancer. Transfus Apher Sci 56(3): 336-340.
  106. Vargas LDN, Garcia LO, Galvão AC, Onsten TG, Coitinho AS, et al. (2014) Blood Transfusion Related Immunomodulation. Clinical & Biomedical Research 34(4): 333.
  107. Obeagu EI, Obeagu GU, Ede MO, Odo EO, Buhari HA (2023) Translation of HIV/AIDS Knowledge into Behavior Change among Secondary School Adolescents in Uganda a Review. Medicine (Baltimore) 102(49): e36599.
  108. Echefu SN, Udosen JE, Akwiwu EC, Akpotuzor JO, Obeagu EI (2023) Effect of Dolutegravir Regimen Against Other Regimens on Some Hematological Parameters, CD4 Count and Viral Load of People Living with HIV Infection in South Eastern Nigeria. Medicine (Baltimore) 102(47): e35910.
  109. Alum EU, Obeagu EI, Ugwu OPC, Samson AO, Adepoju AO, et al. (2023) Inclusion of Nutritional Counseling and Mental Health Services in HIV/AIDS Management a Paradigm Shift. Medicine (Baltimore) 102(41): e35673.
  110. Obeagu EI, Ubosi NI, Uzoma G (2023) Storms and Struggles Managing HIV Amid Natural Disasters. Int J Curr Res Chem Pharm Sci 10(11): 14-25.
  111. Obeagu EI, Obeagu GU (2023) Human Immunodeficiency Virus and Tuberculosis Infection a Review of Prevalence of Associated Factors. Int J Adv Multidiscip Res 10(10): 56-62.
  112. Alum EU, Ugwu OP, Obeagu EI, Aja PM, Okon MB, et al. (2023) Reducing HIV Infection Rate in Women a Catalyst to Reducing HIV Infection Pervasiveness in Africa. International Journal of Innovative and Applied Research 11(10): 01-6.
  113. Storch EK, Custer BS, Menitove JE, Mintz PD (2019) Transfusion Medicine. Concise Guide to Hematology. pp: 463-486.
More from this journal

Cite this article

BibTeX
APA
RIS
@article{emmanuel2024,
  title   = {Immunomodulatory Effects of Blood Transfusion in HIV-Positive Pediatric Severe Malaria Patients: A Review},
  author  = {Emmanuel Ifeanyi Obeagu* and Getrude Uzoma Obeagu},
  journal = {Haematology International Journal},
  year    = {2024},
  volume  = {8},
  number  = {1},
  doi     = {10.23880/hij-16000245}
}
Emmanuel Ifeanyi Obeagu* and Getrude Uzoma Obeagu (2024). Immunomodulatory Effects of Blood Transfusion in HIV-Positive Pediatric Severe Malaria Patients: A Review. Haematology International Journal, 8(1). https://doi.org/10.23880/hij-16000245
TY  - JOUR
TI  - Immunomodulatory Effects of Blood Transfusion in HIV-Positive Pediatric Severe Malaria Patients: A Review
AU  - Emmanuel Ifeanyi Obeagu* and Getrude Uzoma Obeagu
JO  - Haematology International Journal
PY  - 2024
VL  - 8
IS  - 1
DO  - 10.23880/hij-16000245
ER  -